A framework for prioritizing genetic variants for animal modeling in rare disease
This Primer proposes a structured framework for prioritizing genetic variants for animal modeling in rare disease. Drawing on the experience of the Congenital Anomalies Cluster of the UK MRC National Mouse Genetics Network (NMGM), we outline a three-step process: first, rigorous curation of clinical, molecular, and functional evidence to establish biological plausibility and define a mechanistic hypothesis; second, assessment and selection of the most appropriate model capable of addressing the question; and third, integration of practical and ethical considerations, prioritizing variants with clinical actionability, stronger cohorts, and mechanistic potential.
Authors
- Juliana Heather Vedovato dos Santos (ORCID: https://orcid.org/0000-0002-0826-1745)
- Deborah J. Henderson (ORCID: https://orcid.org/0000-0002-2705-5998)
- Karen J. Liu (ORCID: https://orcid.org/0000-0002-2483-2165)
- Stephen R.F. Twigg (ORCID: https://orcid.org/0000-0001-5024-049X)
- Pleasantine Mill (ORCID: https://orcid.org/0000-0001-5218-134X)
- Nicholas D. E. Greene (ORCID: https://orcid.org/0000-0002-4170-5248)
Institutions
- King's College London (GB)
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Mary Lyon Centre at MRC Harwell (GB)
- MRC Weatherall Institute of Molecular Medicine (GB)
- Institute of Genetics and Cancer (GB)
- University College London (GB)
- Newcastle University (GB)
Publication Details
- Journal
- STAR Protocols
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1016/j.xpro.2026.104983
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medical Research Council